Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

        VOLUME 26, ISSUE 1 • March 2022.  Full issue »

The First MDCP Conference on Unanswered Questions and Unsolved Issues in Clinical Practice 


Share this:  

With more than 1,500 registered participants the first MDCP meeting on unanswered questions and unsolved issues in Clinical Practice was held in November in a virtual format. The meeting was celebrated after the journal was formally accepted to Clarivate’s Science Citation Index Expanded (SCIE). MDCP will receive its first impact factor in June 2022.

MDCP began accepting submissions in late 2013 and published its first issue in January 2014. We initially published on a quarterly basis but grew to six issues in 2016 and then ten issues in 2019. Due to growing demand from authors and readers alike, we intend to expand to a monthly publication beginning in 2023.

Since its inception, MDCP has considered the clinical neurologist—at all stages of their career—as its main audience. Perhaps the best definition of MDCP is highlighted by a comment made by a leading clinician in the field who stated “MDCP is the journal that doctors who see patients read”. In line with this, in addition to the video supported material, educational reviews, videos from experts in the ‘How do I” section as well as the recent new addition of genotype-phenotype letters, we took a further step forward to promoting debate and discussion between recognized clinical specialist in the Movement Disorders field in this virtual meeting.

The meeting was focused on the unanswered questions and unmet needs in the field of movement disorders. Obviously, we could not cover every issue, but topics were carefully selected for presentations focusing on areas which are issues in clinical practice.

 

Faculty for the first MDCP conference
Faculty from the first MDCP conference. 

The program was heterogeneous reflecting itself the unanswered questions and unmet needs in practice and therefore it was difficult to structure the sessions under a specific topic. The first day covered topics ranging from advances in genetics, biomarkers, and antibodies to the off-label use of drugs and the new classification of tremor. The second day was also varied and included issues from ICD, gait, and L-dopa nonresponsive symptoms to functional movement disorders and the utility of instrumental technology to evaluate movement disorders. Discussions were led by chairpersons and were often animated and intense.

However, we did feel as the meeting progressed that perhaps the time offered for discussion was relatively limited and in the future longer discussion could be planned. As always, one learns from one’s experiences. Based on the lessons learned from this first conference, we may consider a “non-lecture” format for the next meeting, with only discussions by experts with informed and challenging moderators.

The proceedings of the full conference will be available as an open access virtual video supplement during 2022 and edited discussions will also be published in a viewpoint format covering all the sessions of the meeting.

The success of MDCP and its recently meeting would not be possible without the tremendous support from MDS, its leadership and its members who are an indefatigable source of reviewers and authors. We also thank the large number of dedicated MDS staff earmarked for this event and working behind the scenes to make it the success it was.
 

View the panel videos: 

Day 1 – Panel Discussion 1

Day 1 – Panel Discussion 2 

 

Day 2 – Panel Discussion 1

Day 2 – Panel Discussion 2


Share this:   

Read more Moving Along:

Full issue    Archives

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice